Skip to main content
New hemophilia treatments: ‘Our cup runneth over’
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
New hemophilia treatments: ‘Our cup runneth over’
User login
Username
Password
Reset your password
Concept
Lead
score
Hemophilia
1
1
Gene Therapy
0
0.45
Hemophilia A
0
0.45
Hemorrhage
0
0.45
Biologic Therapy
0
0.36
Prophylaxis
0
0.35
Genomic Medicine
0
0.32
Factor VIII
0
0.3
Christmas Factor
0
0.2
Clinical Research
0
0.2
Hemophilia B
0
0.2
Aminotransferase
0
0.19
Thromboembolism
0
0.13
Intracranial Hemorrhage
0
0.11
Child
0
0.1
Clinical Guidelines
0
0.1
Coagulation
0
0.1
Pharmacokinetics
0
0.1
Thrombosis
0
0.1
Adverse Effects
0
0.05
Anticoagulation Therapy
0
0.05
Antithrombotics
0
0.05
Blood
0
0.05
Board Certification
0
0.05
Factor II
0
0.05
Food and Drug Administration (FDA)
0
0.05
Glucocorticoid
0
0.05
Hematology
0
0.05
Hospital
0
0.05
Intravenous
0
0.05
Liver
0
0.05
Monoclonal Antibody
0
0.05
Patient Safety
0
0.05
Pennsylvania
0
0.05
Plasma
0
0.05
T-Lymphocyte
0
0.05
Tissue
0
0.05
Travel Medicine
0
0.05
Utah
0
0.05
Traumatic Brain Injury
0
0.04
Specialty
Lead
score
Internal Medicine
1
1
Family Medicine/Primary Care
0
1
Hematology-Oncology
0
1
Emergency Medicine
0
0.27
Pharmacist
0
0.25
Public Health & Prevention
0
0.16
Nursing
0
0.05
Edit Tags